Bellicum Pharmaceuticals, Inc.

BST:BPXA Stock Report

Market Cap: €772.4k

Bellicum Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of BPXA?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders116,8410.961%
Institutions450,1013.7%
Hedge Funds3,443,93128.3%
General Public8,152,64867%

Dilution of Shares: Insufficient data to determine if shareholders have been diluted in the past year.


Top Shareholders

Top 11 shareholders own 32.97% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
19.5%
Baker Bros. Advisors LP
2,365,472€150.2k0%no data
8.87%
Armistice Capital LLC
1,078,459€68.5k12.8%no data
3.68%
Ikarian Capital, LLC
448,101€28.5k0%0.01%
0.18%
Jon Stonehouse
22,054€1.4k0%no data
0.16%
Reid Huber
19,494€1.2k0%no data
0.15%
Stephen Davis
18,715€1.2k0%no data
0.12%
Judith Klimovsky
14,602€927.20%no data
0.12%
Charity Scripture
14,587€926.20%no data
0.12%
James Daly
14,377€913.00%no data
0.11%
Richard Fair
13,012€826.30%no data
0.016%
Wetzel Investment Advisors, Inc.
2,000€127.00%no data
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.